These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 11340650)

  • 1. Cannabinoid receptor agonist-stimulated [35S]guanosine triphosphate gammaS binding in the brain of C57BL/6 and DBA/2 mice.
    Basavarajappa BS; Hungund BL
    J Neurosci Res; 2001 May; 64(4):429-36. PubMed ID: 11340650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of cannabinoid receptor agonist-stimulated [35S]GTP gamma S binding in synaptic plasma membrane from chronic ethanol exposed mouse.
    Basavarajappa BS; Hungund BL
    Brain Res; 1999 Jan; 815(1):89-97. PubMed ID: 9974126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct differences in the cannabinoid receptor binding in the brain of C57BL/6 and DBA/2 mice, selected for their differences in voluntary ethanol consumption.
    Hungund BL; Basavarajappa BS
    J Neurosci Res; 2000 Apr; 60(1):122-8. PubMed ID: 10723075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation.
    Darmani NA; Sim-Selley LJ; Martin BR; Janoyan JJ; Crim JL; Parekh B; Breivogel CS
    Eur J Pharmacol; 2003 Jan; 459(1):83-95. PubMed ID: 12505537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist efficacy and receptor efficiency in heterozygous CB1 knockout mice: relationship of reduced CB1 receptor density to G-protein activation.
    Selley DE; Rorrer WK; Breivogel CS; Zimmer AM; Zimmer A; Martin BR; Sim-Selley LJ
    J Neurochem; 2001 May; 77(4):1048-57. PubMed ID: 11359870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-5'-O-(3-[35S]thio)-triphosphate binding assay in rat cerebellar membranes.
    Griffin G; Atkinson PJ; Showalter VM; Martin BR; Abood ME
    J Pharmacol Exp Ther; 1998 May; 285(2):553-60. PubMed ID: 9580597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice.
    Wang L; Liu J; Harvey-White J; Zimmer A; Kunos G
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1393-8. PubMed ID: 12538878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: evidence from postmortem human brain.
    Erdozain AM; Diez-Alarcia R; Meana JJ; Callado LF
    Biochem Pharmacol; 2012 Jan; 83(2):260-8. PubMed ID: 22093909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice.
    Sim-Selley LJ; Martin BR
    J Pharmacol Exp Ther; 2002 Oct; 303(1):36-44. PubMed ID: 12235230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azido- and isothiocyanato-substituted aryl pyrazoles bind covalently to the CB1 cannabinoid receptor and impair signal transduction.
    Howlett AC; Wilken GH; Pigg JJ; Houston DB; Lan R; Liu Q; Makriyannis A
    J Neurochem; 2000 May; 74(5):2174-81. PubMed ID: 10800963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors.
    MacLennan SJ; Reynen PH; Kwan J; Bonhaus DW
    Br J Pharmacol; 1998 Jun; 124(4):619-22. PubMed ID: 9690851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and characterization of NESS 0327: a novel putative antagonist of the CB1 cannabinoid receptor.
    Ruiu S; Pinna GA; Marchese G; Mussinu JM; Saba P; Tambaro S; Casti P; Vargiu R; Pani L
    J Pharmacol Exp Ther; 2003 Jul; 306(1):363-70. PubMed ID: 12663689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid receptor stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding in rat brain membranes.
    Selley DE; Stark S; Sim LJ; Childers SR
    Life Sci; 1996; 59(8):659-68. PubMed ID: 8761016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of SR141716A on G-protein activation in rat brain.
    Sim-Selley LJ; Brunk LK; Selley DE
    Eur J Pharmacol; 2001 Mar; 414(2-3):135-43. PubMed ID: 11239913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional differences in cannabinoid receptor/G-protein coupling in rat brain.
    Breivogel CS; Sim LJ; Childers SR
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1632-42. PubMed ID: 9316881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of spinal cannabinoid 1 receptors inhibits C-fibre driven hyperexcitable neuronal responses and increases [35S]GTPgammaS binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats.
    Drew LJ; Harris J; Millns PJ; Kendall DA; Chapman V
    Eur J Neurosci; 2000 Jun; 12(6):2079-86. PubMed ID: 10886347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain.
    Burkey TH; Quock RM; Consroe P; Ehlert FJ; Hosohata Y; Roeske WR; Yamamura HI
    Eur J Pharmacol; 1997 Oct; 336(2-3):295-8. PubMed ID: 9384246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The great divide: Separation between in vitro and in vivo effects of PSNCBAM-based CB
    Gamage TF; Farquhar CE; Lefever TW; Thomas BF; Nguyen T; Zhang Y; Wiley JL
    Neuropharmacology; 2017 Oct; 125():365-375. PubMed ID: 28803965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid agonist signal transduction in rat brain: comparison of cannabinoid agonists in receptor binding, G-protein activation, and adenylyl cyclase inhibition.
    Breivogel CS; Childers SR
    J Pharmacol Exp Ther; 2000 Oct; 295(1):328-36. PubMed ID: 10991998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation into the structural determinants of cannabinoid receptor ligand efficacy.
    Griffin G; Wray EJ; Rorrer WK; Crocker PJ; Ryan WJ; Saha B; Razdan RK; Martin BR; Abood ME
    Br J Pharmacol; 1999 Apr; 126(7):1575-84. PubMed ID: 10323589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.